Bioton SA - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Bioton SA Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Bioton SA. The Group's principal activity is manufacture of clinically important modern drugs, including recombined human insulin and its pharmaceutical forms, preparations from the cephalosporine, aminoglycoside and macrolide groups. The Group operates in four segments: Insulin and Derivatives, Antibiotics, Growth Hormone and Other. The Group closely co-operates with the Institute of Biotechnology and Antibiotics, which conducts the research of drugs using chemical synthesis and biosynthesis based on genetic engineering methods, and develops technologies of drug manufacturing. In 2008, the Group acquired MJ BIOTON Life Sciences Ltd (Cyprus) and Trice SA (Luxembourg). The Group operates in Poland, Cyprus and Singapore.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report